US Infant Formula Supply Chain Strategy Delivered

FDA immediate actions include ensuring providers know they’re required to develop redundancy risk management plans, enhancing inspections of manufacturers, including by expanding and improving training for investigators, and expediting reviews of premarket submissions for new products.

• Source: Shutterstock

The Food and Drug Administration’s strategy of immediate actions to strengthen the US infant formula supply chain includes ensuring that providers know they’re required to develop and implement redundancy risk management plans.

The strategy detailed in a report the FDA provided within a deadline Congress set in the agency’s fiscal year...

HBW Podcast

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.

More from Regulation

More from Policy & Regulation